coronavirus

  1. Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study

    Merck and partner Ridgeback Biotherapeutics plan to seek U.S. emergency use authorization for the pill as soon as possible, and to submit applications to regulatory agencies worldwide. Due to the positive results, the Phase 3 trial is being stopped early at the recommendation of outside monitors.

    Region:
    World
    Category:
    Society
    Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study
  2. India gingerly eases coronavirus rules as new cases dip to two-month low

    Many Indian states eased coronavirus restrictions on Monday including the capital Delhi, where authorities allowed all shops and malls to open, as the number of new infections dropped to the lowest in more than two months.
    Delhi reports 131 fresh Covid cases, lowest since Feb 22; positivity rate at 0.22%

    Region:
    India
    Category:
    Society
    India gingerly eases coronavirus rules as new cases dip to two-month low
  3. Johnson & Johnson vaccine: CDC lifts suspension amid blood clot concerns

    Advisers to the CDC voted 10-4 to resume the shot’s emergency use authorization in the U.S. for everyone 18 and older. The panel said Friday that the vaccine’s benefits outweigh that serious but small risk — especially against a virus that’s still infecting tens of thousands of Americans every day.

    Region:
    USA
    Category:
    Society
    Johnson & Johnson vaccine: CDC lifts suspension amid blood clot concerns